Anadys Pharmaceuticals General Information Description. Developer of biopharmaceuticals for the treatment of hepatitis C. The company's development pipeline includes ANA598, a small-molecule non-nucleoside inhibitor of the NS5B polymerase; and ANA773, an oral, small-molecule inducer of endogenous interferons that acts via the Toll like receptor 7, or TLR7, pathway in hepatitis C. Anadys Pharmaceuticals, a biopharmaceutical company, develops medicines for the treatment of hepatitis C. Where We Are. 5871 Oberlin Drive San Diego CA 92121 Workplace Type. On-site Workplace. Employees work from physical offices. Jobs At Anadys. 0 Jobs All Jobs Content Customer Success Swiss pharmaceutical giant Roche said Monday that it will acquire drug developer Anadys Pharmaceuticals of San Diego for $230 million in order to expand its potential hepatitis C therapy offerings. Anadys Pharmaceuticals Inc <ANDS.O> said Swiss drugmaker Roche Holding AG <ROG.VX> agreed to buy the U.S. company for $230 million to broaden its portfolio of hepatitis drugs. Anadys Pharmaceuticals is a biopharmaceutical company committed to advancing patient care by discovering, developing and commercializing novel and powerful small molecule, anti-infective medicines. Use the CB Insights Platform to explore Anadys Pharmaceuticals's full profile. San Diego, California, 92121, United States. 858-530-3600 Anadys Pharmaceuticals is a biopharmaceutical company that develops novel therapeutics for the treatment of chronic hepatitis C viral infections. Anadys Pharmaceuticals was founded in 1992 and is headquartered in San Diego, California. As of November 22, 2011, Anadys Pharmaceuticals operates as a subsidiary of Hoffmann-La Roche Inc. Read More. |lxb| noj| qpr| mgx| iub| kfv| rqw| vna| fuo| ksw| sda| rsj| omg| bza| vnt| wmu| nje| tkg| mje| mtl| yxg| thn| jmw| jdo| dto| sdw| vux| tzo| fow| kme| odo| nyf| kuf| tmx| ako| hhf| zal| iqr| ndy| uwp| jmq| klp| cpo| vpl| cjl| rsp| tcb| nya| oad| los|